Ruxolitinib reduces macrophage pyroptosis in aplastic anaemia.

Clin Exp Med · 2026 · PMC12886329 · PMID 41653353

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

Additionally, inflammation-related factors showed a decreasing trend with increasing ruxolitinib concentration (Fig. 1 f).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.